Discover 1,729 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,729
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
for
Cancer, Diabetes
Location: Chapel Hill NC, Tampa FL, Burlington VT
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT07061652
Recruiting
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
for
Smoldering Plasma Cell Myeloma
Location: Chapel Hill NC, Kenansville NC, Kinston NC, Greer SC,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT03937635
Phase3, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Location: Chapel Hill NC, Charlotte NC, Fairfax VA, Bluffton SC,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 12+
Code: NCT02693535
Phase2, Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
for
Refractory Differentiated Thyroid Gland Carcinoma
Location: Chapel Hill NC, Durham NC, Charleston SC, Lexington KY,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT06475989
Phase3, Recruiting
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
for
Smoldering Multiple Myeloma
Location: Durham NC, Charlotte NC, Richmond VA, Columbus OH,
Sponsor: Tufts Medical Center
Sex: All
Age: 40+
Code: NCT06365060
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors